UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer

Journal of clinical oncology, 2005-06, Vol.23 (17), p.3923-3931

2005

Volltextzugriff (PDF)

Pleural Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma

International journal of radiation oncology, biology, physics, 2012-07, Vol.83 (4), p.1278-1283

2012

Volltextzugriff (PDF)

Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma

Journal of clinical oncology, 2009-06, Vol.27 (18), p.3007-3013

2009

Volltextzugriff (PDF)

Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma

Journal of clinical oncology, 2012-07, Vol.30 (20), p.2509-2515

2012

Volltextzugriff (PDF)

New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment

Clinical cancer research, 2012-09, Vol.18 (17), p.4485-4490

2012

Volltextzugriff (PDF)

Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes

Clinical lung cancer, 2016-09, Vol.17 (5), p.e121-e129

2016

Volltextzugriff (PDF)

Failure Patterns After Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma

International journal of radiation oncology, biology, physics, 2014-10, Vol.90 (2), p.394-401

2014

Volltextzugriff (PDF)

Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology

Journal for immunotherapy of cancer, 2023-03, Vol.11 (3), p.e006398

2023

Volltextzugriff (PDF)

The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers

Oncoimmunology, 2015-06, Vol.4 (6), p.e1009285-e1009285

2015

Volltextzugriff (PDF)

Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2004-03, Vol.22 (6), p.1103-1109

2004

Volltextzugriff (PDF)

Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials

Journal of thoracic oncology, 2010-02, Vol.5 (2), p.275-279

2010

Volltextzugriff (PDF)

A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2011-12, Vol.74 (3), p.481-485

2011

Volltextzugriff (PDF)

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer

Journal of clinical oncology, 2018-08, Vol.36 (23), p.2386-2394

2018

Volltextzugriff (PDF)

Phase II Trial of Gefitinib and Everolimus in Advanced Non-small Cell Lung Cancer

Journal of thoracic oncology, 2010-10, Vol.5 (10), p.1623-1629

2010

Volltextzugriff (PDF)

Assessment of Therapy Responses and Prediction of Survival in Malignant Pleural Mesothelioma Through Computer-Aided Volumetric Measurement on Computed Tomography Scans

Journal of thoracic oncology, 2010-06, Vol.5 (6), p.879-884

2010

Volltextzugriff (PDF)

The Evolution of Multimodality Therapy for Malignant Pleural Mesothelioma

Current treatment options in oncology, 2011-06, Vol.12 (2), p.163-172

2011

Volltextzugriff (PDF)

phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies

Cancer chemotherapy and pharmacology, 2010-11, Vol.66 (6), p.1079-1085

2010

Volltextzugriff (PDF)

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma

Journal of clinical oncology, 2016-08, Vol.34 (23), p.2761-2768

2016

Volltextzugriff (PDF)

Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

Journal of thoracic oncology, 2013-03, Vol.8 (3), p.346-351

2013

Volltextzugriff (PDF)

Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin

Clinical cancer research, 2004-09, Vol.10 (18), p.6094-6100

2004

Volltextzugriff (PDF)

Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2016-02, Vol.11 (2), p.249-255

2016

Volltextzugriff (PDF)

Vaccination of Small Cell Lung Cancer Patients with Polysialic Acid or N-Propionylated Polysialic Acid Conjugated to Keyhole Limpet Hemocyanin

Clinical cancer research, 2004-02, Vol.10 (3), p.916-923

2004

Volltextzugriff (PDF)

Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors

Clinical cancer research, 2016-06, Vol.22 (12), p.2874-2884

2016

Volltextzugriff (PDF)

Small-Cell Lung Cancers in Patients Who Never Smoked Cigarettes

Journal of thoracic oncology, 2014-06, Vol.9 (6), p.892-896

2014

Volltextzugriff (PDF)

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(224)
Mit Volltextzugriff
(210)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(238)
Japanisch
(36)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(152)
Humans
(138)
Oncology
(92)
Female
(81)
Male
(80)
Middle Aged
(73)
Aged
(65)
Biological And Medical Sciences
(57)
Medical Sciences
(56)
Adult
(47)
Respiratory System
(45)
Lung Neoplasms - Drug Therapy
(39)
Lung Neoplasms - Pathology
(30)
Aged, 80 And Over
(28)
Treatment Outcome
(24)
Neoplasm Staging
(23)
Pneumology
(23)
Tumors Of The Respiratory System And Mediastinum
(23)
Pharmacology. Drug Treatments
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Thoracic Oncology
(32)
Journal Of Clinical Oncology
(27)
Chest
(14)
Clinical Cancer Research
(12)
Pediatrics
(12)
Cancer
(11)
Lung Cancer
(11)
Journal Of The National Comprehensive Cancer Network
(10)
Seminars In Oncology
(7)
Annals Of The New York Academy Of Sciences
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial

Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer

Pleural Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma

Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma

Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma

New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment

Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes

Failure Patterns After Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma

Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology

The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers

Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials

A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer

Phase II Trial of Gefitinib and Everolimus in Advanced Non-small Cell Lung Cancer

Assessment of Therapy Responses and Prediction of Survival in Malignant Pleural Mesothelioma Through Computer-Aided Volumetric Measurement on Computed Tomography Scans

The Evolution of Multimodality Therapy for Malignant Pleural Mesothelioma

phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma

Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin

Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma

Vaccination of Small Cell Lung Cancer Patients with Polysialic Acid or N-Propionylated Polysialic Acid Conjugated to Keyhole Limpet Hemocyanin

Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors

Small-Cell Lung Cancers in Patients Who Never Smoked Cigarettes

Suchergebnisse filtern